Email this article 
THE EFFICIENCY OF LEVOCETIRIZINE IN TREATMENT OF ALLERGIC SKIN DISEASES
- Authors: Elisyutina OG1, Fedenko ES1, Fedoskova TG1, Luss LV1
-
Affiliations:
- Institute of Immunology
- Issue: Vol 9, No 5 (2012)
- Pages: 69-75
- Section: Articles
- Submitted: 10.03.2020
- Published: 15.12.2012
- URL: https://rusalljournal.ru/raj/article/view/725
- DOI: https://doi.org/10.36691/RJA725
- ID: 725
Cite item
Open Access
Access granted
Abstract
In the article the results of supervision over the patients with chronic urticaria (n=32) and atopic dermatitis (n=30), at the age from 2 till 55 years old treated with H^blocker levocetirizine, are presented. High clinical efficiency and safety of levocetirizine treatment of allergic skin diseases were confirmed.
Keywords
Full Text
About the authors
O G Elisyutina
Institute of Immunology
Email: el-olga@yandex.ru
Moscow, Russia
E S Fedenko
Institute of ImmunologyMoscow, Russia
T G Fedoskova
Institute of ImmunologyMoscow, Russia
L V Luss
Institute of ImmunologyMoscow, Russia
References
- Аллергология и иммунология: национальное руководство. Под ред. Р.М. Хаитова, Н.И. Ильиной. М., «ГЭОТАР-Медиа». 2009, 656 с.
- Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус принт». 1998, 252 с.
- Zuberbier T, Bindslev-Jensen C., Canonica W et al. EAACI/ GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy. 2006, v. 61, p. 316-320.
- Российский национальный согласительный документ «Крапивница и ангиоотек». Рекомендации для практических врачей. Под общей редакцией чл.-корр. РАМН, профессора И.С. Гущина. M., «Фармарус Принт Медиа». 2007, 128 с.
- ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of AD. J. Eur. Acad. Dermatol Venereol. 2010, v. 24, p. 317-328.
- Murota H., Kitaba S., Tani M. et al. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergology Intern. 2010, v. 59, p. 345-354.
- Paus R., Schmelz M., Biro T. et al. Frontiers in pruritis research: scratching the brain for more effective itch therapy. J. Clin. Invest. 2006, v. 116, p. 1174-1185.
- Steinhoff M., Bienenstock J., Schmelz M. Neurophysiological, neuroimmunological and neuroendocrine basis of pruritus. J. Invest. Dermatol. 2006, v. 126, p. 1705-1718.
- Standler S., Stenfonhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp. Dermatol. 2002, v. 11, p. 12-24.
- Klein P. A., Clark R.A. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch. Dermatol. 1999, v. 135, p. 1522-1525.
- Herman S.M., Vender R.B. Antihistamines in the treatment of dermatitis. J. Cutan. Med. Surg. 2003, v. 7, p. 467-473.
- Феденко Е.С. Симптом кожного зуда при атопическом дерматите. Рос. Аллергол. Журн. 2004, № 1, с. 42-47.
- Simons F.E. Early Prevention of Asthma in Atopic Children Study Group. Hj-antihistamine treatment in young atopic children: effect on urticaria. Ann. Allergy Asthma Immunol. 2007, v. 99 (3), p. 261-266.
- Pampura A.N., Papadopoulos N.G., Spicak V., Kurzawa R. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease. Int. Arch. Allergy Immunol. 2011, v. 155 (4), p. 367-378.
- Mahmoud F. et al. Intracellular cytokine production in children with atopic dermatitis: effect of levocetirizine treatment. Pedijatrijadanas. 2009, v. 5, p. 162-171.
- Stadler J.F., Taieb A. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology. 1993, v. 186, p. 23-31.
- Finlay A.Y., Khan G.K. Dermatology Life Quality Index (DLQI) — a simple practical measure for routine clinical use. Clin. Exp. Dermatol. 1994, v. 19 (3), p. 210-216.
Supplementary files
